7,441,387 warrants exercised in Biovica's October 2023 rights issue raised SEK 19M for product rollout and partnerships.

Biovica International AB has reported that 7,441,387 warrants from its October 2023 rights issue were exercised, representing about 42.73% of the total. This action raised approximately SEK 19 million to support the rollout of its DiviTum® TKa product in the US and Europe and to foster partnerships within the pharmaceutical sector. The company's share capital increased by SEK 496,092, bringing the total to SEK 6,519,092.

October 03, 2024
3 Articles